Literature DB >> 2707639

Effect of bile acid on anorectal function in man.

C A Edwards1, S Brown, A J Baxter, J J Bannister, N W Read.   

Abstract

The effects of rectal infusions (500 ml) of deoxycholic acid (1 mmol/l, 3 mmol/l) or normal saline on basal anorectal motility and responses to rectal distension were studied in 11 normal volunteers. Deoxycholic acid (1 mmol/l) did not alter anorectal motor patterns under basal conditions but reduced the rectal volumes required to induce a desire to defecate (deoxycholic acid 76 (12) ml v saline 123 (12) ml; mean (SEM) p less than 0.01), and to produce anal relaxation (deoxycholic acid 83 (14) ml v saline 152 (24) ml; p less than 0.05) and perception of the rectal balloon (deoxycholic acid 56 (10) ml v saline 104 (17) ml; p less than 0.01) that were sustained for the period of distension (1 min). Seven of 10 subjects could not tolerate an infusion of 3 mmol/l deoxycholic acid. Between two and 30 minutes after the start of the infusion they experienced an extreme urge to defecate which was associated with large amplitude pressure waves in the rectal channels (amplitude 30 (5) mmHg, duration 0.7 (0.1) min, frequency 1.7 (0.4)/min). Such contractions were never seen during saline infusion. Thus, rectal infusion of deoxycholic acid at physiological concentrations increases the sensitivity of the rectum to distension, and promotes an urgent desire to defecate in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707639      PMCID: PMC1378463          DOI: 10.1136/gut.30.3.383

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.

Authors:  A F Hofmann; J R Poley
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

2.  Bile acids and colonic motility in the rabbit and the human.

Authors:  W O Kirwan; A N Smith; W D Mitchell; J D Falconer; M A Eastwood
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

3.  Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man.

Authors:  H S Mekjian; S F Phillips; A F Hofmann
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

4.  Effect of deoxycholic acid on colonic motility in the rabbit.

Authors:  W J Snape; S Shiff; S Cohen
Journal:  Am J Physiol       Date:  1980-04

5.  Dose-related effects of chenodeoxycholic acid in the rabbit colon.

Authors:  M Camilleri; R Murphy; V S Chadwick
Journal:  Dig Dis Sci       Date:  1980-06       Impact factor: 3.199

6.  Bile acids in the diarrhoea of ileal resection.

Authors:  W D Mitchell; J M Findlay; R J Prescott; M A Eastwood; D B Horn
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

7.  Effect of bile acid perfusion on colonic motor function in patients with the irritable colon syndrome.

Authors:  I Taylor; P Basu; P Hammond; C Darby; M Flynn
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

8.  Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention.

Authors:  M V Merrick; M A Eastwood; M J Ford
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02

9.  The effect of bile acids on colonic myoelectrical activity.

Authors:  M Flynn; C Darby; J Hyland; P Hammond; I Taylor
Journal:  Br J Surg       Date:  1979-11       Impact factor: 6.939

  9 in total
  19 in total

1.  Postinfectious Irritable Bowel Syndrome.

Authors:  Kok-Ann Gwee
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

2.  Effect of cholecystectomy on bowel function: a prospective, controlled study.

Authors:  S D Hearing; L A Thomas; K W Heaton; L Hunt
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

3.  In vitro recordings of afferent fibres with receptive fields in the serosa, muscle and mucosa of rat colon.

Authors:  P A Lynn; L A Blackshaw
Journal:  J Physiol       Date:  1999-07-01       Impact factor: 5.182

4.  Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study.

Authors:  Anil Minocha; William D Johnson; Thomas L Abell; William Chad Wigington
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

5.  Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation.

Authors:  Atsushi Yamamoto; Takaomi Kessoku; Kosuke Tanaka; Kota Takahashi; Yuki Kasai; Anna Ozaki; Michihiro Iwaki; Takashi Kobayashi; Tsutomu Yoshihara; Noboru Misawa; Kanji Ohkuma; Akiko Fuyuki; Takuma Higurashi; Kunihiro Hosono; Masato Yoneda; Tomoyuki Iwasaki; Takeo Kurihashi; Machiko Nakatogawa; Ayao Suzuki; Masataka Taguri; Shunsuke Oyamada; Keisuke Ariyoshi; Noritoshi Kobayashi; Yasushi Ichikawa; Atsushi Nakajima
Journal:  Contemp Clin Trials Commun       Date:  2022-06-27

6.  Bowel function and irritable bowel symptoms after hysterectomy and cholecystectomy--a population based study.

Authors:  K W Heaton; D Parker; H Cripps
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

7.  Comparison of the effects of ispaghula and wheat bran on rat caecal and colonic fermentation.

Authors:  C A Edwards; M A Eastwood
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

Review 8.  Bowel function after urinary diversion.

Authors:  Antony C P Riddick; William H Turner; Robert D Mills
Journal:  World J Urol       Date:  2004-08-31       Impact factor: 4.226

9.  Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons.

Authors:  Henri Duboc; Ganna Tolstanova; Pu-Qing Yuan; Vincent Wu; Izumi Kaji; Mandy Biraud; Yasutada Akiba; Jonathan Kaunitz; Mulugeta Million; Yvette Tache; Muriel Larauche
Journal:  Neurogastroenterol Motil       Date:  2016-06-03       Impact factor: 3.598

10.  A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.

Authors:  William D Chey; Michael Camilleri; Lin Chang; Leif Rikner; Hans Graffner
Journal:  Am J Gastroenterol       Date:  2011-05-24       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.